Voronoi Health Analytics develops AI-powered medical imaging software and services for clinicians, researchers, and healthcare organizations. Its tools transform CT, PET/CT, and MRI scans into quantitative data, supporting analysis of body composition, organs, tumors, lesions, cardiac plaques, adipose tissue, and metabolic activity. The company’s solutions are designed to run on-premise or on-device, including on PCs and data-center systems, and support research and clinical workflows.

Its Data Analysis Facilitation Suite (DAFS) offers automated whole-body image quantification and visualization, alongside products for rapid single-slice body composition analysis, DICOM integration with PACS, and removal of identifying information from DICOM headers. DAFS-CT is identified on the website as an FDA 510(k)-cleared Class II software medical device. Voronoi also provides full-service project reading, data preprocessing and curation, measurement extraction, custom reports, and statistical analysis with visualization. These services cover metrics such as organ volumes, radiodensity, body composition, and tumor measurements. Established in body composition research, the company highlights more than a decade of technology development and research publications.